Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia

Open access

Abstract

Treatment-resistant schizophrenia (TRS) affects around one-third of individuals with schizophrenia. Although a number of sociodemographic and clinical predictors of TRS have been identified, data on the genetic risk of TRS are sparse. We aimed to investigate the association between a polygenic risk score for schizophrenia and treatment resistance in patients with schizophrenia. We conducted a nationwide, population-based follow-up study among all Danish individuals born after 1981 and with an incident diagnosis of schizophrenia between 1999 and 2007. Based on genome-wide data polygenic risk scores for schizophrenia were calculated in 862 individuals with schizophrenia. TRS was defined as either clozapine initiation or at least 2 periods of different antipsychotic monotherapies and still being hospitalized. We estimated hazard rate ratios (HRs) for TRS in relation to the polygenic risk score while adjusting for population stratification, age, sex, geographical area at birth, clinical treatment setting, psychiatric comorbidity, and calendar year. Among the 862 individuals with schizophrenia, 181 (21.0%) met criteria for TRS during 4674 person-years of follow-up. We found no significant association between the polygenic risk score and TRS, adjusted HR = 1.13 (95% CI: 0.95-1.35). Based on these results, the use of the polygenic risk score for schizophrenia to identify individuals with TRS is at present inadequate to be of clinical utility at the individual patient level. Future research should include larger genetic samples in combination with non-genetic markers. Moreover, a TRS-specific developed polygenic risk score would be of great interest towards early prediction of TRS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/schbul/sbx007

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 5

  1. NICE Project Team GDG, 2014, NICE Guideline 178. Psychosis and Schizophrenia in Adults: Treatment and Management
  2. National Collaborating Centre for Mental H, 2009, Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update). NICE Clinical Guidelines, No. 82
  3. 2009, Kliniske retningslinier for behandling med antipsykotika [Clinical Guidelines for Treatment With Antipsychotics]
  4. 1998, Behandling med antipsykotika. Vejledende retningslinjer. [Treatment With Antipsychotics. Guidelines]
  5. , : å [ ]; 2014, Baggrundsnotat for medicinsk behandling af psykotiske tilstande [Background Note for Medical Treatment of Psychotic States]

Cited by

See all 91

Metadata

Authors
Wimberley, T., Gasse, C., Meier, S. M., Agerbo, E., MacCabe, J. H., & Horsdal, H. T.
Affiliations
  • Aarhus University (DK)
  • King's College London (GB)
Corresponding author
Wimberley, Theresa
Venue
Schizophrenia Bulletin
Published
2017-02-10
Volume
43
Issue
5
Pages
1064-1069
ISSN
  • 0586-7614 (ISSN-L)
  • 1745-1701
OpenAlex
W2586701058
Cited by
89
References
30
Citations by year
2026: 5 · 2025: 3 · 2024: 13 · 2023: 10 · 2022: 15 · 2021: 9 · 2020: 8 · 2019: 14 · 2018: 9 · 2017: 3
FWCI
7.64
Type
journal article
Language
en
Open access
Locations
  • Schizophrenia Bulletin (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Funders
  • South London and Maudsley NHS Foundation Trust
  • National Institute for Health and Care Research (FP7/2007–2013)
  • King's College London
  • European Commission (279227)
  • Lundbeckfonden (R155-2014-1724)
  • H. Lundbeck A/S (R155-2014-1724)
  • Medical Research Council (MR/L011794/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
treatment-resistant schizophrenia, polygenic risk score
MeSH terms
Adolescent, Adult, Denmark, Drug Resistance, Female, Follow-Up Studies, Humans, Male, Registries, Risk, Schizophrenia, Antipsychotic Agents, Genetic Predisposition to Disease, Multifactorial Inheritance, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia. https://app.cochat.ai/papers/10.1093/schbul/sbx007
The paper
Wimberley, T., Gasse, C., Meier, S. M., Agerbo, E., MacCabe, J. H., & Horsdal, H. T. (2017). Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbx007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.